In MetS, however, signaling downstream of KLF2 may be impaired due to altered ERK5 or MEF2 activity (which are required for full transcriptional activation), oxidative stress, or epigenetic modifications, resulting in uncoupling between KLF2 and its canonical targets [64]. Here, MAPK7 is linked to metabolic syndrome.